相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The impact of a supranetwork multidisciplinary team (SMDT) on decision-making in testicular cancers: a 10-year overview of the Anglian Germ Cell Cancer Collaborative Group (AGCCCG)
Jonathan Shamash et al.
BRITISH JOURNAL OF CANCER (2021)
A Risk-benefit Analysis of Prophylactic Anticoagulation for Patients with Metastatic Germ Cell Tumours Undergoing First-line Chemotherapy
Christian Daniel Fankhauser et al.
EUROPEAN UROLOGY FOCUS (2021)
Metachronous Contralateral Testicular Cancer in the Cisplatin Era: A Population-Based Cohort Study
Ragnhild Hellesnes et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Circulating MicroRNAs, the Next-Generation Serum Biomarkers in Testicular Germ Cell Tumours: A Systematic Review
Ricardo Leao et al.
EUROPEAN UROLOGY (2021)
Retroperitoneal Lymph Node Dissection Versus Surveillance for Adult Early Stage Pure Testicular Teratoma: A Nationwide Analysis
Ali Hajiran et al.
ANNALS OF SURGICAL ONCOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Late adverse effects and quality of life in survivors of testicular germ cell tumour
Michal Chovanec et al.
NATURE REVIEWS UROLOGY (2021)
Oncological outcome and complications of post-chemotherapy retroperitoneal surgery in non-seminomatous germ cell tumours - a systematic review
Josephine J. Rosenvilde et al.
ACTA ONCOLOGICA (2021)
Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium
Silke Gillessen et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium
Jorg Beyer et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Thromboembolic Events During Treatment with Cisplatin-based Chemotherapy in Metastatic Testicular Germ-cell Cancer 2000-2014: A Population-based Cohort Study
Hege S. Haugnes et al.
EUROPEAN UROLOGY OPEN SCIENCE (2021)
Testicular cancer incidence predictions in Europe 2010-2035: A rising burden despite population ageing
Ariana Znaor et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Comparison between CT and MRI in detection of metastasis of the retroperitoneum in testicular germ cell tumors: a prospective trial
Marjut Laukka et al.
ACTA ONCOLOGICA (2020)
The 111 Study: A Single-arm, Phase 3 Trial Evaluating One Cycle of Bleomycin, Etoposide, and Cisplatin as Adjuvant Chemotherapy in High-risk, Stage 1 Nonseminomatous or Combined Germ Cell Tumours of the Testis
Michael Cullen et al.
EUROPEAN UROLOGY (2020)
Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I Nonseminoma
Stefanie Fischer et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Cardiovascular Risk Factors and Disease After Male Germ Cell Cancer
Jakob Lauritsen et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Genomic Characterization of Testicular Germ Cell Tumors Relapsing After Chemotherapy
Andrea Necchi et al.
EUROPEAN UROLOGY FOCUS (2020)
Testicular Cancer Biomarkers: A Role for Precision Medicine in Testicular Cancer
Ricardo Leao et al.
CLINICAL GENITOURINARY CANCER (2019)
Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study
Klaus-Peter Dieckmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Association of Inherited Pathogenic Variants in Checkpoint Kinase 2 (CHEK2) With Susceptibility to Testicular Germ Cell Tumors
Saud H. AlDubayan et al.
JAMA ONCOLOGY (2019)
Family history of cancer and risk of paediatric and young adult's testicular cancer: A Norwegian cohort study
Ruby Del Risco Kollerud et al.
BRITISH JOURNAL OF CANCER (2019)
Developing a Highly Specific Biomarker for Germ Cell Malignancies: Plasma miR371 Expression Across the Germ Cell Malignancy Spectrum
Lucia Nappi et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Predictors of thrombosis in testicular cancer during platinum-based chemotherapy
Pia Paffenholz et al.
WORLD JOURNAL OF UROLOGY (2019)
European Association of Urology Guidelines on Testis Cancer: Important Take Home Messages
Axel Heidenreich et al.
EUROPEAN UROLOGY FOCUS (2019)
MRI of the scrotum: Recommendations of the ESUR Scrotal and Penile Imaging Working Group
Athina C. Tsili et al.
EUROPEAN RADIOLOGY (2018)
ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up
F. Honecker et al.
ANNALS OF ONCOLOGY (2018)
Testicular Tumour Size and Rete Testis Invasion as Prognostic Factors for the Risk of Relapse of Clinical Stage I Seminoma Testis Patients Under Surveillance: a Systematic Review by the Testicular Cancer Guidelines Panel
Joost L. Boormans et al.
EUROPEAN UROLOGY (2018)
Large-scale Analysis Demonstrates Familial Testicular Cancer to have Polygenic Aetiology
Chey Loveday et al.
EUROPEAN UROLOGY (2018)
Therapeutic approaches for refractory germ cell cancer
Christoph Oing et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2018)
Clinical Stage IIA-IIC Seminoma: Radiation Therapy versus Systemic Chemotherapy versus Retroperitoneal Lymph Node Dissection
Gunhild von Amsberg et al.
ONCOLOGY RESEARCH AND TREATMENT (2018)
Questioning the Value of Fluorodeoxyglucose Positron Emission Tomography for Residual Lesions After Chemotherapy for Metastatic Seminoma: Results of an International Global Germ Cell Cancer Group Registry
Richard Cathomas et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Incidentally detected testicular lesions <10 mm in diameter: can orchidectomy be avoided?
Glenda Scandura et al.
BJU INTERNATIONAL (2018)
The World Health Organization 2016 classification of testicular germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation Panel
Sean R. Williamson et al.
HISTOPATHOLOGY (2017)
Prognostic Factors and Treatment Results After Bleomycin, Etoposide, and Cisplatin in Germ Cell Cancer: A Population-based Study
Maria G. Kier et al.
EUROPEAN UROLOGY (2017)
Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours
Klaus-Peter Dieckmann et al.
EUROPEAN UROLOGY (2017)
UICC drops the ball in the 8th edition TNM staging of urological cancers
Brett Delahunt et al.
HISTOPATHOLOGY (2017)
Outcome of Men With Relapse After Adjuvant Carboplatin for Clinical Stage I Seminoma
Stefanie Fischer et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Meta-analysis of five genome-wide association studies identifies multiple new loci associated with testicular germ cell tumor
Zhaoming Wang et al.
NATURE GENETICS (2017)
Value of Multiparametric US in the Assessment of Intratesticular Lesions
Thomas Auer et al.
RADIOLOGY (2017)
Value of Supraregional Multidisciplinary Review for the Contemporary Management of Testicular Tumors
Karin Purshouse et al.
CLINICAL GENITOURINARY CANCER (2017)
Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA)
T. Tandstad et al.
ANNALS OF ONCOLOGY (2016)
Germ cell neoplasia in situ (GCNIS): evolution of the current nomenclature for testicular pre-invasive germ cell malignancy
Daniel M. Berney et al.
HISTOPATHOLOGY (2016)
Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell Tumors
Aditya Bagrodia et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Brain Metastases in Patients With Germ Cell Tumors: Prognostic Factors and Treatment Options-An Analysis From the Global Germ Cell Cancer Group
Darren R. Feldman et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Testicular germ cell tumours
Ewa Rajpert-De Meyts et al.
LANCET (2016)
MALE REPRODUCTIVE DISORDERS AND FERTILITY TRENDS: INFLUENCES OF ENVIRONMENT AND GENETIC SUSCEPTIBILITY
Niels E. Skakkebaek et al.
PHYSIOLOGICAL REVIEWS (2016)
Targeted therapies in germ cell tumors
Christian M. Squillante et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2015)
Hypogonadism and fertility issues following primary treatment or testicular cancer
Jan Oldenburg
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2015)
Radiotherapy or chemotherapy for clinical stage IIA and IIB seminoma: a systematic review and meta-analysis of patient outcomes
P. Giannatempo et al.
ANNALS OF ONCOLOGY (2015)
Phase 2 Trial of the Cyclin-Dependent Kinase 4/6 Inhibitor Palbociclib in Patients With Retinoblastoma Protein-Expressing Germ Cell Tumors
David J. Vaughn et al.
CANCER (2015)
One course of adjuvant BEP in clinical stage I nonseminoma mature and expanded results from the SWENOTECA group
T. Tandstad et al.
ANNALS OF ONCOLOGY (2014)
Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG)
J. Aparicio et al.
ANNALS OF ONCOLOGY (2014)
A Nationwide Cohort Study of Stage I Seminoma Patients Followed on a Surveillance Program
Mette Sakso Mortensen et al.
EUROPEAN UROLOGY (2014)
Screening, Assessment, and Management of Fatigue in Adult Survivors of Cancer: An American Society of Clinical Oncology Clinical Practice Guideline Adaptation
Julienne E. Bower et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Surveillance for Stage I Nonseminoma Testicular Cancer: Outcomes and Long-Term Follow-Up in a Population-Based Cohort
Gedske Daugaard et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial
Karim Fizazi et al.
LANCET ONCOLOGY (2014)
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer
J. Beyer et al.
ANNALS OF ONCOLOGY (2013)
MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours
K-P Dieckmann et al.
BRITISH JOURNAL OF CANCER (2012)
Serum Levels of MicroRNAs miR-371-3: A Novel Class of Serum Biomarkers for Testicular Germ Cell Tumors?
Gazanfer Belge et al.
EUROPEAN UROLOGY (2012)
Retroperitoneal lymphadenectomy and resection for testicular cancer: an update on best practice
Axel Heidenreich et al.
THERAPEUTIC ADVANCES IN UROLOGY (2012)
A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis germ-cell cancer. An intergroup study of EORTC, GTCSG, and Grupo Germinal (EORTC 30974)
G. Daugaard et al.
ANNALS OF ONCOLOGY (2011)
Long-Term Survival After Treatment with Gemcitabine and Oxaliplatin With and Without Paclitaxel Plus Secondary Surgery in Patients with Cisplatin-Refractory and/or Multiply Relapsed Germ Cell Tumors
Karin Oechsle et al.
EUROPEAN UROLOGY (2011)
Risk of metachronous contralateral testicular germ cell tumors: a population-based study of 7,102 Norwegian patients (1953-2007)
Kristine E. Andreassen et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Randomized Trial of Carboplatin Versus Radiotherapy for Stage I Seminoma: Mature Results on Relapse and Contralateral Testis Cancer Rates in MRC TE19/EORTC 30982 Study (ISRCTN27163214)
R. Timothy D. Oliver et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Second cancers after testicular cancer diagnosed after 1980 in Sweden
K. Hemminki et al.
ANNALS OF ONCOLOGY (2010)
Poor prognosis nonseminomatous germ-cell tumours (NSGCTs): should chemotherapy doses be reduced at first cycle to prevent acute respiratory distress syndrome in patients with multiple lung metastases?
C. Massard et al.
ANNALS OF ONCOLOGY (2010)
TI-CE High-Dose Chemotherapy for Patients With Previously Treated Germ Cell Tumors: Results and Prognostic Factor Analysis
Darren R. Feldman et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Prognostic Factors in Patients With Metastatic Germ Cell Tumors Who Experienced Treatment Failure With Cisplatin-Based First-Line Chemotherapy
Joerg Beyer et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
American Society of Clinical Oncology Clinical Practice Guideline on Uses of Serum Tumor Markers in Adult Males With Germ Cell Tumors
Timothy D. Gilligan et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Serum tumor markers in the evaluation of male germ cell tumors
LaMont J. Barlow et al.
NATURE REVIEWS UROLOGY (2010)
Assessing prognosis and optimizing treatment in patients with postchemotherapy viable nonseminomatous germ-cell tumors (NSGCT): results of the sCR2 international study
K. Fizazi et al.
ANNALS OF ONCOLOGY (2008)
[18F]-FDG-PET in clinical stage I/II non-seminomatous germ cell tumours: results of the German multicentre trial
M. de Wit et al.
ANNALS OF ONCOLOGY (2008)
Combination chemotherapy with gemcitabine, oxaliplatin, and paclitaxel in patients with cisplatin-refractory or multiply relapsed germ-cell tumors:: a study of the German Testicular Cancer Study Group
C. Bokemeyer et al.
ANNALS OF ONCOLOGY (2008)
High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors
Lawrence H. Einhorn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
18Fluorodeoxyglucose positron emission tomography in the prediction of relapse in patients with high-risk, clinical stage I nonseminomatous germ cell tumors: Preliminary report of MRC trial TE22 - The NCRI testis tumour clinical study group
Robert A. Huddart et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Phase II trial of the novel epothilone ZK-EPO in patients with platinum resistant ovarian cancer
G. J. Rustin et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Randomized trial of two or five computed tomography scans in the surveillance of patients with stage I nonseminomatous germ cell tumors of the testis: Medical Research Council Trial TE08, ISRCTN56475197 - The National Cancer Research Institute Testis Cancer Clinical Studies Group
Gordon J. Rustin et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Late recurrences of germ cell malignancies:: a population-based experience over three decades
J Oldenburg et al.
BRITISH JOURNAL OF CANCER (2006)
Risk-adapted management for patients with clinical stage I seminoma:: The second Spanish germ cell cancer cooperative group study
J Aparicio et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The risk of thrombo-embolic events is increased in patients with germ-cell tumours and can be predicted by serum lactate dehydrogenase and body surface area
AC Piketty et al.
BRITISH JOURNAL OF CANCER (2005)
The continued value of central histopathological review of testicular tumours
RJ Delaney et al.
HISTOPATHOLOGY (2005)
A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours
JL Pico et al.
ANNALS OF ONCOLOGY (2005)
Clinical pattern and therapeutic results achieved in 1490 patients with germ-cell tumours of the testis:: the experience of the Spanish Germ-Cell Cancer Group (GG)
JR Germà-Lluch et al.
EUROPEAN UROLOGY (2002)
Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients
CA Dykewicz
CLINICAL INFECTIOUS DISEASES (2001)
RPLND or primary chemotherapy in clinical stage IIA/B nonseminomatous germ cell tumors? Results of a prospective multicenter trial including quality of life assessment
L Weissbach et al.
EUROPEAN UROLOGY (2000)
分享论文
